NT Peg LS Tablet contains a combination of Pregabalin 50mg and Nortriptyline 10mg, formulated for the management of neuropathic pain and certain types of chronic pain disorders. Pregabalin is an anticonvulsant and neuropathic pain agent that modulates calcium channels to reduce neurotransmitter release, thereby diminishing nerve pain and seizure activity. Nortriptyline, a tricyclic antidepressant, exerts analgesic effects by inhibiting the reuptake of norepinephrine and serotonin, enhancing descending inhibitory pain pathways. This combination provides a synergistic effect, improving pain control in conditions such as diabetic neuropathy, postherpetic neuralgia, and fibromyalgia. NT Peg LS Tablet is indicated for patients who require both neuropathic pain relief and mood stabilization, particularly when monotherapy is insufficient. The medication should be used under medical supervision, with careful dose titration to minimize adverse effects such as dizziness, sedation, dry mouth, and potential cardiovascular effects associated with nortriptyline. Caution is advised in patients with a history of cardiac disease, glaucoma, or renal impairment. NT Peg LS Tablet is contraindicated in individuals with hypersensitivity to either component. Regular monitoring and adherence to prescribed dosing are essential to optimize therapeutic outcomes and ensure patient safety.